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Highlights 
 
 Limited evidence is available on the association between markers of arterial 
stiffness and atrial fibrillation amongst Asian populations. 
 
 Augmentation index (AI), a marker of arterial stiffness, was measured by an 
automated tonometer the HEM-9000AI device.  
 
 Atrial fibrillation was estimated by using resting electrocardiograph (ECG). 
 
 AI values were positively associated with the prevalence of atrial fibrillation and 
total arrhythmia, independent of cardiovascular risk factors. 
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Background and aims: Limited evidence is available on the association between 
markers of arterial stiffness and the prevalence of atrial fibrillation among Asian 
populations. Therefore, we examined those associations amongst Japanese population. 
Methods: We conducted a cross-sectional population-based study of 4,264 men and 
women aged 40-79 years. The augmentation index (AI), a marker of arterial stiffness, 
was calculated as the ratio of central pulse pressure/brachial pulse pressure, where the 
AI and central aortic pressure were measured by an automated tonometer the 
HEM-9000AI device (Omron Healthcare co., Kyoto, Japan). Atrial fibrillation was 
estimated by the Minnesota codes using resting electrocardiograph (ECG). 
Results: The prevalence of atrial fibrillation and total arrhythmia were higher with 
larger AI values. These associations did not change after adjustment for known 
cardiovascular risk factors. The multivariable odd ratios (95% confidence intervals) in 
the highest versus lowest tertiles of AI were 3.4 (1.4-8.6, P for trend = 0.008) for atrial 
fibrillation and 1.8 (1.2-2.7, P for trend = 0.004) for total arrhythmia. There was no 
association of central or brachial pulse pressure levels with the prevalence of atrial 
fibrillation or total arrhythmia.  
Conclusion: AI values, but not brachial or central pulse pressures, were positively 
associated with the prevalence of atrial fibrillation and total arrhythmia, independent 
of cardiovascular risk factors. (Words: 211) 
Key words: Arterial stiffness, central pulse pressure; augmentation index; atrial 
fibrillation; epidemiology  
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1. Introduction  
The speed of the left ventricular ejected pulse into the systemic arteries increases 
steadily in patients with aortic stiffness, and this makes the reflected pressure 
returns back early [1]. A meta-analysis of 11 prospective cohort studies has 
confirmed that markers of aortic stiffness such as central and brachial pulse 
pressures (PP) and augmentation index (AI) were associated with risk of 
cardiovascular and total mortalities and those associations were more evident for 
central PP than for brachial PP [2]. However, brachial PP was also associated with 
risk of new-onset atrial fibrillation [3]; which is a well-known risk factor for stroke 
and total death [4].  
Few studies, however, have investigated the association between these markers 
of aortic stiffness and risk of atrial fibrillation [5-7]. AI values, but not brachial PP 
values, were positively associated with risk of atrial fibrillation in a Japanese 
case-control study; in which associations with central PP were not examined [5]. An 
Australian patients-based study showed that higher values of AI and central PP were 
more strongly associated with recurrence of atrial fibrillation than that brachial PP [6]. 
The association was stronger for AI than for central PP according to an American 
population-based cohort study [7]. On the light of the above limited evidence, we 
aimed to investigate the relationships of AI, central PP and brachial PP with risk of 
arrhythmia including atrial fibrillation and premature beats by using data from a large 
population-based cohort of Japanese population. Our hypothesis is that markers of 
arterial stiffness, especially AI, may be associated with risk of higher prevalence of 
atrial fibrillation and total arrhythmia. 
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2. Materials and methods 
2.1. Subjects  
Since 1963, the CIRCS has started annual cardiovascular risk surveys in a Japanese 
community-based cohort [8]. A total of 5,705 persons (2,253 men and 3,452 women) 
aged 40-79 years who attended the annual cardiovascular risk surveys between 
January 2010 and November 2012 in three communities of CIRCS: Yao City of Osaka 
Prefecture; Ikawa town of Akita Prefecture and Kyowa town of Ibaraki Prefecture. 
Out of them, 4,264 participates (1,593 men and 2,671 women) undertook AI 
measurement and thus eligible for this study (Supplemental Figure 1). Participants 
were 549 men and 912 women in Yao (recruitment rate among the cardiovascular 
surveys participants =78% for men and 74% for women), 472 men and 763 women in 
Ikawa (recruitment rate =79% for men and 85% for women) and 572 men and 996 
women in Kyowa (recruitment rate= 60% for men and 76% for women). The 
informed consent was obtained from all subjects. The study protocol was approved by 
the Ethics Committee of Osaka University, and was explained in detail by physicians, 
epidemiologists and trained staff members, for each participant.  
 
2.2. Measurement of AI and cardiovascular risk factors 
Protocol-standardized measurements of radial AI and central aortic pressure [9,10] 
using the automated tonometer, HEM-9000AI (Omron, Healthcare co., Kyoto, Japan) 
by trained technicians were conducted for participants in a sitting position after 5 
minutes of rest. The second systolic peaks of the radial artery systolic blood pressure 
(SBP2) were obtained by calibrating the radial waveforms with brachial systolic 
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pressure, and the SBP2 values were considered as the central aortic pressure levels 
[10]. The central PP was defined as the central aortic systolic pressure minus the 
brachial diastolic blood pressure, and the brachial PP was defined as the systolic 
minus the diastolic brachial blood pressures. The AI value was calculated as central 
PP/brachial PP × 100 (%) [10], and AI measurement was normalized by the heart rate 
of 75 bpm for the analysis [11].  
The details for cardiovascular risk factors and other covariates’ measurements 
and procedures of quality-control for the current study have been reported earlier 
[9,12]. In brief, body mass index (BMI) was calculated as weight (kg) divided by the 
square of height (m2). Seated right arm brachial systolic and diastolic blood pressures 
were measured by trained technicians via standard mercury sphygmomanometers after 
giving 5 minutes rest for the participants [13]. Two trained physician-epidemiologists 
used the Minnesota code to classify the resting electrocardiograph (ECG) that was 
obtained in supine position [14]. Minnesota codes 8-3-1 and 8-3-2 were defined as 
atrial fibrillation; codes 8-1-1 and 8-1-2 were defined as premature beats including 
atrial and ventricular premature beats; and the codes 8-1-1, 8-1-2, 8-3-1, 8-3-2, and 
8-9-1 were defined as total arrhythmia. A fasting glucose level of ≥7.8 mmol/L, a 
non-fasting glucose level of ≥11.1 mmol/L or the use of medication for diabetes 
mellitus defined participants with diabetes mellitus. A systolic blood pressure ≥140 
mmHg and diastolic blood pressure ≥90 mmHg or the use of medications to lower 
blood pressure defined hypertensive participants. 
Serum was separated within 30 minutes from collecting non-fasting blood 
samples that were drawn from participants in sitting position and collected in plain 
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siliconised glass tube. An automatic analyser (Hitachi 7250, Hitachi Medical Corp., 
Ibaraki, Japan) provided readings for serum total and HDL-cholesterol and 
triglycerides levels using enzymatic method and serum glucose levels using 
hexokinase method at an international member of the US National Cholesterol 
Reference Method Laboratory Network (CRMLN); the Osaka Medical Centre for 
Health Science and Promotion [15].  
Current smokers were participants who smoked ≥1 cigarette per day. Via an 
interview, the weekly alcohol intake in the traditional Japanese “go” units, that was 
then converted into daily grams ethanol intake (1“go” unit =23 g of ethanol) was 
assessed.  
 
2.3. Statistical analysis 
We analysed the association of brachial PP, central PP and AI values with the 
prevalence of atrial fibrillation, premature beats and total arrhythmia in all subjects, 
because those association did not vary by sex; P for interaction >0.05. Differences in 
age- and sex-adjusted and multivariable-adjusted odds ratios (ORs) and 95% 
confidence intervals (CIs) for atrial fibrillation, premature beats and total arrhythmia 
were calculated by using logistic regression analysis across increasing tertiles of 
brachial PP levels (<42, 42-52, and >53 mmHg); central PP levels (<43, 43-55, and 
>56 mmHg) and AI values (<79, 79-87, and >88%) with the lowest tertile of each as 
reference.  
The hypothesized confounders in the current study included age (years), 
communities, sex, BMI (kg/m2), systolic blood pressure (mmHg), smoking status 
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(never, ex- and current), drinking status (never, ex- and current: <46 and excessive 
drinking of ≥46g/day), heart rate (beats/minute), history of diabetes mellitus (yes or 
no), the use of antihypertensive medication (yes or no) and cholesterol-lowering 
medication (yes or no) and serum total and HDL-cholesterol and triglycerides levels 
(mmol/L). All p values for statistical tests were two-tailed, and values of p <0.05 were 
regarded as indicative of statistical significance, using the SAS statistical package 
version 9.4 (SAS Institute Inc., Cary, CA).
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3. Results 
Table 1 shows the age- and sex- adjusted population characteristics of selected 
cardiovascular risk factors according to tertiles of brachial and central PP and AI 
levels. When compared with participants in the lowest tertiles of brachial and central 
PP and AI levels, those in the highest tertiles were older, with higher levels of AI, 
central aortic and brachial systolic blood pressures and were more likely to be 
hypertensives. Mean values of alcohol consumption, triglyceride levels, prevalence of 
diabetes and medication use for hypertension were positively associated with brachial 
and central PP levels. Whereas, the prevalence of diabetes and use of 
cholesterol-lowering medications were lower across increasing AI levels. There were 
no statistical differences for total and HDL-cholesterol levels and smoking status 
among tertiles of brachial and central PP and AI levels. 
The ORs (95% CI) of ECG-confirmed arrhythmias according to tertiles and 1-SD 
increment of central and brachial PP and AI levels were shown in Table 2. The 1-SD 
increment of AI was associated with1.6, 1.3 and 1.3-fold increased odds for risks of 
atrial fibrillation, premature beats and total arrhythmia, respectively. Compared with 
participants in the lowest tertile of AI levels, age- and sex- adjusted prevalence of 
atrial fibrillation and total arrhythmia, but not of premature beats were higher for those 
in the highest tertile of AI levels. These associations did not change substantially after 
adjustment for known cardiovascular risk factors; the multivariable ORs (95% CI) 
were 3.4 (1.4-8.6, P for trend = 0.008) for atrial fibrillation, 1.4 (0.7-2.6, P for trend = 
0.30) for premature beats and 1.8 (1.2-2.7, P for trend = 0.004) for total arrhythmia. 
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There were no association of brachial or central PP levels with prevalence of atrial 
fibrillation, premature beats or total arrhythmia.  
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4. Discussion 
In the present community population-based study of 4,264 Japanese men and women 
aged 40-79 years, participants in the highest AI tertile displayed approximately two- 
to three-fold higher prevalence of atrial fibrillation and total arrhythmia than those in 
the lowest tertile. There were no associations of brachial or central PP with the 
prevalence of arrhythmia including atrial fibrillation.  
Our finding of association between AI values and arrhythmia is consistent with 
the results from previous studies [5-7]. A 7-year follow-up study of 5,797 Americans 
aged ≥45 years has shown that hazard ratio (95%CI) of atrial fibrillation was 1.16 
(1.02-1.32) per 1-SD (12.4%) increment of AI values [7]. A 3-year follow-up study of 
68 atrial fibrillation patients, after initial catheter ablation procedure, indicated that 
patients in the highest quartile of AI values versus those in the lowest quartile had 
1.6-fold increased recurrent rates of atrial fibrillation [6]. A case-reference study of 
244 outpatients with atrial fibrillation showed that atrial fibrillation patients had 
higher mean of AI values than control subjects: mean ± SD = 88.9 ±1.0 versus 81.8 
±1.0, respectively, p<0.001 [5].  
Values of AI [6,7], central PP [6,7] and brachial PP [3] were associated with risk 
of new-onset atrial fibrillation. Increased levels of AI values and central and brachial 
PP levels are markers for increased left ventricular load and left ventricular 
hypertrophy [16], which can elevate the pressure in the left atrium causing left atrial 
dilatation and atrial fibrillation [17]. However, after atrial fibrillation occurs, central 
and brachial blood pressures and their PPs decline [18-20]; while AI, the ratio of 
central and brachial PPs, remains a significant covariate for atrial fibrillation. This 
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implies that high AI may be the better surrogate marker for atrial fibrillation as well as 
aortic stiffness. Moreover, AI values but not brachial systolic pressure levels were 
positively associated with higher prevalence of left ventricular mass index [21]. In 
Australian patients-based study showed that higher values of AI and central PP were 
associated with higher risk of atrial fibrillation [6]. A population-based cohort study 
followed 5,797 American men and women aged ≥45 years for 7.1 years indicated that 
AI values rather than central PP levels were associated with risk of atrial fibrillation. 
The multivariable HR per 1-SD increment of AI values and central PP levels in that 
study were 1.16 (1.02-1.32, P=0.02) and 1.11(0.98-1.25, P=0.09), respectively [7]. 
Elevated AI might be a marker of concentric left ventricular hypertrophy, which may 
explain the association with incident atrial fibrillation [7]. 
On the other hand, the correlation of central PP with the intima media thickness 
of carotid arteries was stronger than that of brachial PP among 3,520 Americans aged 
18 to 88 years (r=0.293 vs. 0.249, respectively, p < 0.002) [22]. A meta-analysis of 
5,648 subjects with a mean of 45 months follow-up revealed that central PP was 
associated more strongly with mortality from cardiovascular disease and all causes 
than brachial PP: the relative risk (95%CI) was 1.32(1.22-1.42) versus 
1.19(1.10-1.28), p=0.057 [2]. 
The strengths of the present study include the validated population-based 
assessment of cardiovascular risk factors [8,12] and measuring central aortic pressure 
and AI values via a non-invasive technique. We used the automated tonometer 
HEM-9000AI to assess central aortic pressure and AI values rather than the invasive 
standard direct cardiac catheterisation measurements; however, the correlation of 
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central aortic pressure levels was high between the two measurement systems (r= 0.95, 
p < 0.001) among 18 hypertension patients aged 47-78 years [23]. Second, the 
cross-sectional design of the current study disabled us from drawing a causal 
relationship. Third, the ECGs were examined only once; however, the internal quality 
control for data collection and ECG reading in CIRCS [8] made the misclassification 
for evaluated arrhythmias small.  
In conclusion, high AI values were associated with increased prevalence of atrial 
fibrillation and total arrhythmia independent of cardiovascular risk factors among 
general population. 
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 Table 1 Age-and sex-adjusted population characteristics according to tertiles of brachial and central pulse pressure levels and augmentation index values 
*p<0.05, †p<0.01, ‡p<0.001 compared with the lowest tertile. 
 
 
 Brachial pulse pressure, mmHg  Central pulse pressure, mmHg  Augmentation index, % 
Tertile Low Middle High  Low Middle  High  Low Middle  High 
           
Total number 1,388 1,511 1,365  1,404 1,443 1,417  1,467 1,311 1,486 
Men, %  39 37 36  41 37* 34‡  38 38 36 
Age, year 58.4 61.8‡ 66.2‡  58.5 61.8‡ 65.8‡  59.6 62.8‡ 63.9‡ 
Brachial pulse pressure, mmHg 36.2 47.7‡ 63.1‡  42.3 47.8‡ 56.6‡  48.2 48.8 49.7‡ 
Systolic blood pressure, mmHg 111.6 123.6‡ 137.9‡  118.3 123.1‡ 131.5‡  121.4 124.5‡ 127.0‡ 
Diastolic blood pressure, mmHg 75.4 75.9 74.8  76.0 75.3 74.9†  73.2 75.7‡ 77.3‡ 
Central aortic pressure, mmHg 118.1 125.6‡ 136.6‡  111.0 124.6‡ 144.2‡  116.7 127.1‡ 136.1‡ 
Augmentation index, % 83.0 83.2 84. 5‡  78.6 83.1‡ 88.8‡  72.9 83.4‡ 94.1‡ 
Body mass index, kg/m2 23.1 23.4† 23.6‡  23.2 23.4 23.6†  23.5 23.5 23.1† 
Total cholesterol, mmol/L 5.48 5.52 5.48  5.46 5.48 5.54*  5.49 5.49 5.50 
HDL-cholesterol, mmol/L 1.67 1.66 1.64  1.66 1.66 1.66  1.67 1.66 1.65 
Triglycerides, mmol/L 1.18 1.22 1.32‡  1.21 1.22 1.29*  1.22 1.23 1.28 
Alcohol intake, g/day 15.6 17.8 20.1†  16.2 17.8 19.7*  17.8 17.5 18.1 
Current smoker, % 37 37 38  37 38 36  35 38 38 
Hypertension, % 23 29‡ 59‡  27 33† 51‡  33 36 41‡ 
Antihypertensive medication, % 10 14† 18‡  10 13* 18‡  14 14 13 
Cholesterol-lowering medication, % 10 10 12  10 11 10  12 10 9† 
Diabetes mellitus, % 8 11† 17‡  10 13* 13*  13 13 10* 
22 
 
Table 2. Odds ratios (95%CIs) of arrhythmia according to tertiles of brachial and central pulse pressure levels and augmentation index values 
1 Minnesota codes 8-3-1 and 8-3-2. 2 Minnesota codes 8-1-1 and 8-1-2. 3 Minnesota codes 8-1-1, 8-1-2, 8-3-1, 8-3-2, and 8-9-1. 
*p<0.05, †p<0.01, ‡p<0.001, compared with the lowest tertile.  
** Multivariable OR. 1-SD of brachial PP, central PP and augmentation index were respective 16.5, 12.9 and 11.0. 
OR: odds ratio. Multivariable adjustment for age, sex, BMI, heart rate, systolic blood pressure, smoking and drinking status, serum total and HDL-cholesterol, triglycerides, diabetes mellitus, 
antihypertensive medication and cholesterol-lowering medication use and communities.  
 Branchial pulse pressure, mmHg P for 
trend 
Central pulse pressure, mmHg P for 
trend 
Augmentation index, % P for 
trend Tertiles Low Middle  High Low Middle  High Low Middle  High 
Total number 1,388 1,511 1,365  1,404 1,443 1,417  1,467 1,311 1,486  
Atrial fibrillation1, n 13 12 12  15 10 12  8 10 19  
Age- and sex- adjusted OR 1.0 0.7 (0.3-1.6) 0.5 (0.2-1.2) 0.13 1.0 0.6 (0.3-1.4) 0.7 (0.3-1.7) 0.51 1.0 1.3 (0.5-3.4) 2.4 (1.0-5.8) 0.03 
Multivariable adjusted OR 1.0 0.7 (0.3-1.7) 0.5 (0.2-1.2) 0.53 1.0 0.7 (0.3-1.8) 1.1 (0.5-2.9) 0.75 1.0 1.5 (0.6-4.2) 3.4 (1.4-8.6)† 0.008 
1-SD increment OR**         1.0 (0.6-1.7)         0.9 (0.6-1.4)            1.6 (1.1-2.3)†  
Premature beats2, n   18 28 24  27 20 23  18 26 26  
Age- and sex- adjusted OR 1.0 1.3 (0.7-2.4) 1.1 (0.6-2.4) 0.88 1.0 0.6 (0.4-1.2) 0.7 (0.4-1.2) 0.22 1.0 1.5 (0.8-2.8) 1.3 (0.7-2.4) 0.40 
Multivariable adjusted OR 1.0 1.3 (0.7-2.3) 1.1 (0.6-2.1) 0.16 1.0 0.7 (0.4-1.3) 0.8 (0.4-1.5) 0.54 1.0 1.6 (0.8-2.9) 1.4 (0.7-2.6) 0.30 
1-SD increment OR**        1.2 (0.8-1.7)       0.9 (0.6-1.1)            1.3 (1.0-1.7)*  
Total arrhythmia3, n   57 70 66  71 58 64  46 70 77  
Age- and sex- adjusted OR 1.0 1.0 (0.7-1.4) 0.9 (0.6-1.2) 0.39 1.0 0.7 (0.5-1.0) 0.7 (0.5-1.1) 0.14 1.0 1.6 (1.1-2.4)* 1.6 (1.1-2.3)* 0.02 
Multivariable adjusted OR 1.0 1.0 (0.7-1.4) 0.8 (0.6-1.2) 0.66 1.0 0.8 (0.5-1.1) 0.9 (0.6-1.3) 0.53 1.0 1.7 (1.2-2.5)† 1.8 (1.2-2.7)† 0.004 
1-SD increment OR**        0.8 (0.7-1.1)      0.9 (0.8-1.1)           1.3 (1.1-1.6)‡  
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Supplemental Figure legend 
 
Supplemental Figure 1.  
Recruitment of study participants aged 40 to 79 years in annual cardiovascular risk survey from January, 2010 to November, 2012  
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Participant’s flow chart 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5,705 participants (2,253 men and 3,452 women) aged 40-79 years participated in the annual cardiovascular risk surveys 
between January 2010 and November 2012 in three communities of CIRCS study 
Yao City of Osaka Prefecture    
702 men and 1,239 women 
Kyowa town of Ibaraki Prefecture   
956 men and 1,318 women 
 
Ikawa town of Akita Prefecture    
595 men and 895 women 
480 (153 men 
and 327 women) 
706 (384 men 
and 322 women) 
255 (123 men 
and 132 women) 
549 men and 912 women 
 
572 men and 996 women 
 
472 men and 763 women 
 
4,264 participates (1,593 men and 2,671 women) measured AI 
 
No measurement of AI No measurement of AI No measurement of AI  
